FDA-approved 5-HT1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injury - Concepedia

Concepedia

Publication | Open Access

FDA-approved 5-HT1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injury

DOI Full Paper Access

30

Citations

39

References

2021

Year

Epiphani C. Simmons, Natalie E. Scholpa, Rick G. Schnellmann

Experimental Neurology

NeuroregenerationSpinal Cord InjuryMedicineEnhances LocomotorSpinal TraumaNeuropharmacologyNeuroprotectionNeurologyPharmacologySpinal DisorderOxidative Stress

References

	Year	Citations

Page 1